RONALD YEARWOOD: Open Payments
NPI 1457374423 · LYONS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$700 in 28 payments from 13 companies in 2025. Trend: 2023 $975 · 2024 $625 · 2025 $700
Food & beverage: $588Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $160 |
| E.R. Squibb & Sons, L.L.C. | 6 | $153 |
| ABBVIE INC. | 3 | $81 |
| Alkermes, Inc. | 4 | $68 |
| Axsome Therapeutics, Inc. | 3 | $51 |
| Vanda Pharmaceuticals Inc. | 1 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $30 |
| Janssen Pharmaceuticals, Inc | 2 | $29 |
| Lundbeck LLC | 1 | $28 |
| Indivior Inc. | 1 | $19 |
Products named: COBENFY, VRAYLAR, REXULTI, Auvelity, ARISTADA, HETLIOZ, VIVITROL, UZEDY.
Industry payments across NY — which companies pay providers there.
